NCT02175901View on ClinicalTrials.gov

Amoxicillin/Metronidazole Based Quadruple Therapy for Helicobacter Pylori Eradication

PHASE4CompletedINTERVENTIONAL
Enrollment

215

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
DyspepsiaPeptic Ulcer
Interventions
DRUG

Lansoprazole

antisecretory drug of each quadruple therapy

DRUG

Bismuth Potassium Citrate

one component of each quadruple therapy

DRUG

Amoxicillin

antibiotic of each quadruple therapy

DRUG

Metronidazole

antibiotic of the amoxicillin/metronidazole-based quadruple therapy

DRUG

Clarithromycin

antibiotic of the amoxicillin/clarithromycin-based quadruple therapy

Trial Locations (1)

200127

Shanghai Renji Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT02175901 - Amoxicillin/Metronidazole Based Quadruple Therapy for Helicobacter Pylori Eradication | Biotech Hunter | Biotech Hunter